[1]
Kashif Rauf, Tehmina Qamar,Bashir Ahmad, Shoaib Malik, Nadeem Naseem, Naseer ud Din, K.R.T.Q.A.S.M.N.N.N. ud D. 2019. Effects on ALT normalization in the first month of treatment by Sofosbuvir/Ribavirin therapy versus Sofosbuvir/Daclatasvir therapy in HCV infected individuals. Journal of Rawalpindi Medical College. 23, 4 (Dec. 2019).